申请人:Shionogi & Co., Ltd.
公开号:US04256640A1
公开(公告)日:1981-03-17
Tetrahydrothiopyrano[2,3-b]indole derivative represented by the formula I: ##STR1## wherein R.sup.1 is hydrogen, alkyl, hydroxyalkyl, alkenyl, aralkyl, aryl, --COR.sup.5 (wherein R.sup.5 is alkyl, alkenyl, aryl or alkoxy) or ##STR2## (wherein Y is alkylene, oxoalkylene, hydroxyalkylene and R.sup.6 and R.sup.7 are each hydrogen or alkyl): R.sup.2 is hydrogen or alkyl; R.sup.3 is hydrogen, alkyl, hydroxyalkyl, alkenyl, aralkyl, aryl or dialkylaminoalkyl or ##STR3## is pyrrolidino, piperidino, piperazino, 4-alkylpiperazino, 4-arylpiperazino or morpholino; R.sup.4 is hydrogen or alkyl; A is methylene, alkylmethylene, ethylene, alkylethylene; X is hydrogen or one or two groups selected from the group consisting of halogen, alkyl, alkoxy, hydroxy and halogenoalkyl; and n is an integer of 0 to 2 and its pharmaceutically acceptacle salts; synthesized from 2-propargylthioindole or 2-(4-hydroxy-2-butynylthio)-indole; useful as analgesic and anti-inflammatory agent.
I: ##STR1##其中R.sup.1为氢,烷基,羟基烷基,烯基,芳基烷基,芳基,-COR.sup.5(其中R.sup.5为烷基,烯基,芳基或烷氧基)或##STR2##(其中Y为烷基,氧代烷基,羟基烷基,R.sup.6和R.sup.7各自为氢或烷基);R.sup.2为氢或烷基;R.sup.3为氢,烷基,羟基烷基,烯基,芳基烷基,芳基或二烷基氨基烷基或##STR3##为吡咯啉基,哌啶基,哌嗪基,4-烷基哌嗪基,4-芳基哌嗪基或吗啉基;R.sup.4为氢或烷基;A为亚甲基,烷基亚甲基,乙烯基,烷基乙烯基;X为氢或从卤素,烷基,烷氧基,羟基和卤代烷基组成的一到两个基团;n为0到2的整数及其药学上可接受的盐;由2-丙炔硫吲哚或2-(4-羟基-2-丁炔基硫基)-吲哚合成;用作镇痛和抗炎药。